Cite
HARVARD Citation
Pelizzaro, F. et al. (2022). Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival. Digestive and liver disease. 54 (7), pp. 927-936. [Online].